Your account is not claimed yet. You can sign up with ORCID to claim your account.

Megan M Wyatt

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 4

Top Topics

Immune Response

Fluorescent Probe

Intellectual Disability

Top Venues

Cancer immunology, immunotherapy : CII

Cancer research

Nature communications

bioRxiv : the preprint server for biology

Medical University of South Carolina

College of Charleston (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Medical University of South Carolina Jun 15o 2015

United States

Research Specialist III :: Microbiology and Immunology

Education History

College of Charleston

United States

MSC :: Biology

Publications

Guillermo O Rangel Rivera, Connor J Dwyer, Hannah M Knochelmann, Aubrey S Smith, Arman Aksoy, Anna C Cole, Megan M Wyatt, Jessica E Thaxton, Gregory B Lesinski, Chrystal M Paulos
The degree of T cell stemness differentially impacts the potency of adoptive cancer immunotherapy in a Lef-1 and Tcf-1 dependent manner. bioRxiv : the preprint server for biology (2023)
Guillermo O Rangel Rivera, Connor J Dwyer, Hannah M Knochelmann, Aubrey S Smith, Bülent Arman Aksoy, Anna C Cole, Megan M Wyatt, Soundharya Kumaresan, Jessica E Thaxton, Gregory B Lesinski, Chrystal M Paulos
Progressively enhancing stemness of adoptively transferred T cells with PI3Kδ blockade improves metabolism and anti-tumor immunity. Cancer research (2023)
Matthew J Scheffel, Gina Scurti, Megan M Wyatt, Elizabeth Garrett-Mayer, Chrystal M Paulos, Michael I Nishimura, Christina Voelkel-Johnson
N-acetyl cysteine protects anti-melanoma cytotoxic T cells from exhaustion induced by rapid expansion via the downmodulation of Foxo1 in an Akt-dependent manner. Cancer immunology, immunotherapy : CII 67 (4) (2018)
Stefanie R Bailey, Michelle H Nelson, Kinga Majchrzak, Jacob S Bowers, Megan M Wyatt, Aubrey S Smith, Lillian R Neal, Keisuke Shirai, Carmine Carpenito, Carl H June, Michael J Zilliox, Chrystal M Paulos
Human CD26high T cells elicit tumor immunity against multiple malignancies via enhanced migration and persistence. Nature communications 8 (1) (2017)